Thought this was interesting.
An article on the ALS Association website from Feb, 2024.
Subsiding/grants to help 6 companies with pre-clinical drug development to fast track most promising areas for ALS.
Have a look at the first two - promoting Autophagy!
We are clearly in an area already heavily targetted as having huge potential.
This little Aussie biotech coming out of nowhere with highly successful phase 1 clinical trial results under it's belt , preparing for phase 2/3, must be causing quite a stir.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1208
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.14M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 21.0¢ | $109.7K | 513.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 281695 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 27964 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |